Haywood, Cilla

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Riesmeyer, J. S., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 3,163

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Botros, F. T., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 638

Treatment of obesity in older persons—A systematic review

Haywood, C., & Sumithran, P. (2019) · Obesity Reviews

Bariatric Surgery and OutcomesPharmacology and Obesity Treatment

Cited by 84

Very Low Calorie Diets for Weight Loss in Obese Older Adults—A Randomized Trial

Haywood, C. J., Prendergast, L. A., Purcell, K., Le Fevre, L., Lim, W. K., Galea, M., & Proietto, J. (2018) · The Journals of Gerontology: Series A

Nutrition and Health in AgingDiet and metabolism studies

Cited by 48

Obesity in older adults: Effect of degree of weight loss on cardiovascular markers and medications

Haywood, C. J., Prendergast, L. A., Lim, R., Lappas, M., Lim, W. K., & Proietto, J. (2019) · Clinical Obesity

Diabetes, Cardiovascular Risks, and LipoproteinsDiet and metabolism studies

Cited by 19

Australian and New Zealand Society for Geriatric Medicine: Position Statement – Obesity and the older person

Visvanathan, R., Haywood, C. J., Piantadosi, C., & Appleton, S. (2012) · Australasian Journal on Ageing

Cited by 17